Skip to main content
OpenTrials

Clinical trial condition

Demyelinating Diseases

Explore clinical trials studying Demyelinating Diseases. Study availability and eligibility vary by location and protocol.

2,936 public trials 460 recruiting studies
Refine in advanced search Browse all conditions

Demyelinating Diseases trial results

Completed

Evaluation of Patient Retention of Fingolimod vs. Currently Approved Disease Modifying Therapy in Patients With Relapsing Remitting Multiple Sclerosis.

NCT01623596

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Novartis Investigative Site Cullman, Alabama, United States
  • Novartis Investigative Site Phoenix, Arizona, United States
  • Novartis Investigative Site Sun City, Arizona, United States
  • Novartis Investigative Site Tucson, Arizona, United States
View all 123 locations
View Trial Details
Completed

BG00012 Monotherapy Safety and Efficacy Extension Study in Multiple Sclerosis (MS)

NCT00835770

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +10 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Huntsville, Alabama, United States
  • research Site Mesa, Arizona, United States
  • Research Site Phoenix, Arizona, United States
View all 246 locations
View Trial Details
Completed

The Evaluation of Potential Zika, Chikungunya, and Dengue Infections in Mexico

NCT02831699

Conditions
Alphavirus Infections, Arbovirus Infections, Autoimmune Diseases, +28 more
Locations
  • Hospital General de Tapachula Tapachula, Chiapas, Mexico
  • Hospital Regional de Alta Especialidad Ciudad Salud Chiapas, Mexico
  • Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado (ISSSTE) Clínica Hospital Dr. Roberto Nettel Flores Chiapas, Mexico
  • Instituto Mexicano del Seguro Social (IMSS) Delegación Estatal / Hospital General de Zona con Medicina Familiar No. 1 Chiapas, Mexico
View Trial Details
Completed

CLARITY Extension Study

NCT00641537

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Research Site Boulder, Colorado, United States
  • Research Site Atlanta, Georgia, United States
  • Research Site Chicago, Illinois, United States
  • Research Site Northbrook, Illinois, United States
View all 116 locations
View Trial Details
Completed

Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis (MS)

NCT02294058

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Xenosciences Inc Phoenix, Arizona, United States
  • St Josephs Hospital and Medical Center Phoenix, Arizona, United States
  • Northwest Neuro Specialists PLLC Tucson, Arizona, United States
  • Alta Bates Summit Medical Center Berkeley, California, United States
View all 224 locations
View Trial Details
Completed

Evaluate Safety/Tolerability in Portuguese Participants With RRMS Transitioning From Current Therapy

NCT03177083

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Hospital Fernando Fonseca Amadora, Portugal
  • Hospital de Braga Braga, Portugal
  • Centro Hospitalar Cova da Beira Covilha, Portugal
  • Hospital Evora Evora, Portugal
View all 15 locations
View Trial Details

Related conditions